IMMU-14. ONCOLYTIC ADENOVIRUS DELTA-24-RGD ENGINEERED TO EXPRESS 4-1BBL AS A THERAPEUTIC APPROACH FOR DIPG

Despite the advances in our understanding of pediatric diffuse midline gliomas (DMG) they remain the leading cause of pediatric death caused by cancer. Our group has demonstrated that the administration of Delta-24-RGD in DIPG models is safe and therapeutically efficacious. An on-going clinical tria...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Laspidea, Virginia, Puigdelloses, Montserrat, Martinez-Velez, Naiara, Garcia-Moure, Marc, Labiano, Sara, Ausejo, Iker, Patiño-García, Ana, Becher, Oren J, Jiang, Hong, Gupta, Sumit, Fueyo, Juan, Gomez-Manzano, Candelaria, M Alonso, Marta
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651280/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.444
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky